Jie Xu; Fujun Wang; Miao Xie; Yangyang Huang; Xinlong Liu; Yuanyuan Guo; Xinyuan Zhu; Chuan Zhang*; Lijuan Zhu*; Modification-Powered Engineering of The Aptamer-Based Proteolysis Targeting Chimeras for Enhanced Membrane Protein Degradation. CCS Chem. 2025.
Junjie Ren; Shiyin Zhao; Dali Wang; Yao Wang; Wei Huang; Feng Zhu*; Lijuan Zhu*; Deyue Yan*; Mannosylated siRNA/PERKi Nanoassemblies Reprogram Macrophages to Block Tumor Metastasis. Nano Today 2026, 67: 102975.
Zhenghong Zhou; Han Ma; Jie Zhou; Yang Sun; Rongfeng Wu; Sen Gao; Shiyin Zhao; Bing Liu; Yong Nian; Bo Yang*; Lijuan Zhu*; Feng Zhu*; Photocatalyzed Decarboxylative B−C Couplings for the Synthesis of Carboranyl Amino Acids and Peptides. J. Am. Chem. Soc. 2025, 147(39): 35531-35543.
Lijuan Zhu; Jiapei Yang; Yuan Ma; Xinyuan Zhu; Chuan Zhang*; Aptamers Entirely Built from Therapeutic Nucleoside Analogues for Targeted Cancer Therapy. J. Am. Chem. Soc. 2022, 144(4): 1493-1497.
Shuai-Shuai Fang; XiangJun Hu; Ming-Hong Li; Shuang Qi; Tian Xie; Jia-Bao Wang; Hong-Qing Yao; Jian Zhang; Jun-Hua Zhang*; Lijuan Zhu*; Ming Shang*; Ligand-Enabled Cu-Catalyzed Stereoselective Synthesis of P-Stereogenic ProTides. J. Am. Chem. Soc. 2024, 146, 45, 31339-31347.
Lijuan Zhu; Yuanyuan Guo; Qiuhui Qian; Deyue Yan; Yuehua Li; Xinyuan Zhu; Chuan Zhang*; Carrier-free delivery of precise drug-chemogene conjugates for synergistic treatment of drug-resistant cancer. Angew. Chem. Int. Ed. 2020, 59(41): 17944-17950.
Lijuan Zhu; Jie Xu; Junjie Ren; Mei Yang; Changjie Yang; Xiaobo Gao; Alberto Bianco*; Ding-Kun Ji*; A Biodegradable 2D Metallic MoS2 Genesheet for Synergistic NIR-II Photothermal Immunotherapy. Small 2025, 21(30): 2502577.
Anrong Chen; Yang Han; Rongfeng Wu; Bo Yang; Lijuan Zhu*; Feng Zhu*; Palladium-Catalyzed Suzuki-Miyaura Cross-Couplings of Stable Glycal Boronates for Robust Synthesis of C-1 Glycals. Nat. Commun. 2024, 15, 5228.
Kai Jiang; Zhenyi Lin; Mingrui Cheng; Yanmin Chen; Yiru Jiang; Changhua Xu*; Lijuan Zhu*; Bo Gong*; Chuan Zhang*; Jiaxu Hong*; Itaconate-Functionalized Tetrahedral Framework Nucleic Acids Break the Dry Eye Vicious Cycle Through Dual Antioxidant and Anti-Inflammatory Actions. J. Nanobiotechnol. 2025, 23: 699.
Yimeng Li; Fei Ding; Lijuan Zhu*; Hao Feng*; Chuan Zhang*; Advances in Oligonucleotide Therapeutics: Recent Bench-side Progress in ASO, siRNA, and Aptamer. Mater. Today, 2026, 94: 103204.